infecti
bronchiti
ib
acut
highli
contagi
viral
diseas
chicken
ib
affect
chicken
age
base
organ
system
affect
diseas
manifest
three
major
clinic
renal
reproduct
ib
caus
great
econom
loss
poultri
industri
worldwid
infecti
bronchiti
viru
ibv
member
genu
gammacoronaviru
famili
coronavirida
viral
genom
singlestrand
positivesens
rna
kb
length
viral
genom
code
nonstructur
protein
respons
rna
replic
transcript
viral
genom
code
four
structur
protein
name
spike
envelop
e
membran
nucleocapsid
n
protein
addit
sever
nonstructur
protein
protein
ibv
heavili
glycosyl
play
major
role
elicit
protect
immun
respons
present
trimer
surfac
virion
contain
conform
depend
epitop
protein
cleav
posttransl
host
cell
proteas
ntermin
globular
head
domain
ctermin
stalk
domain
subunit
subunit
variabl
subunit
harbor
major
neutral
epitop
receptor
bind
domain
rbd
respons
viral
attach
tissu
tropism
subunit
conserv
subunit
involv
mediat
membran
fusion
viral
entri
protein
also
contain
minor
neutral
epitop
contribut
avid
protein
shown
tyrosin
motif
locat
cytoplasm
tail
protein
respons
intracellular
retent
tyrosin
residu
essenti
product
viru
infect
howev
role
tyrosin
residu
induct
protect
immun
respons
ibv
protein
studi
mani
differ
ibv
serotyp
genotyp
circul
worldwid
serotyp
aris
due
high
frequenc
mutat
andor
recombin
event
crossprotect
differ
serotyp
variabl
poor
egypt
classic
variant
strain
ibv
cocircul
caus
frequent
diseas
outbreak
major
ibv
variant
strain
report
egypt
belong
lineag
egyptian
variant
strain
mostli
relat
strain
also
known
isra
variant
ii
isra
variant
iirel
serotyp
also
report
mani
countri
middl
east
north
africa
recent
poland
turkey
liveattenu
vaccin
highli
success
control
ib
field
howev
liveattenu
vaccin
provid
crossprotect
ibv
variant
furthermor
use
liveattenu
ibv
vaccin
lead
product
variant
ibv
strain
mutat
andor
recombin
egypt
classic
variant
liveattenu
vaccin
strain
mainli
use
control
ib
although
vaccin
provid
good
protect
variant
virus
provid
poor
protect
preval
variant
field
virus
belong
lineag
liveattenu
vaccin
also
sourc
gener
new
variant
virus
therefor
altern
vaccin
strategi
benefici
control
ib
outbreak
egypt
viral
vector
vaccin
provid
altern
approach
liveattenu
ibv
vaccin
vector
vaccin
express
protect
antigen
ibv
lead
creation
variant
virus
attempt
made
express
subunit
protein
use
fowl
pox
viru
herp
viru
adenoviru
vector
howev
none
vaccin
effect
provid
complet
protect
ibv
suggest
need
new
vaccin
vector
use
newcastl
diseas
viru
ndv
vaccin
vector
ibv
hold
great
promis
ndv
member
genu
avulaviru
famili
paramyxovirida
ndv
caus
highli
contagi
diseas
substanti
mortal
chicken
natur
avirul
ndv
strain
lasota
wide
use
live
ndv
vaccin
chicken
year
good
record
safeti
stabil
ndv
replic
effici
respiratori
tract
chicken
induc
mucos
immun
site
ibv
entri
also
elicit
strong
humor
cellmedi
immun
respons
crucial
clearanc
ibv
moreov
use
dual
vaccin
ibv
ndv
recombin
ndv
rndv
use
previous
vaccin
vector
evalu
protect
efficaci
protein
ibv
report
rndv
express
protein
provid
partial
protect
virul
ibv
challeng
rndv
express
ibv
protein
provid
partial
protect
singl
vaccin
better
protect
observ
booster
vaccin
recent
shown
rndv
express
whole
protein
classic
ibv
strain
provid
better
protect
rndv
express
protein
ibv
goal
studi
evalu
protect
efficaci
three
form
protein
egyptian
ibv
lineag
variant
strain
use
ndv
vaccin
vector
addit
express
wild
type
protein
second
protein
express
tyrosin
residu
cytoplasm
tail
mutat
alanin
modifi
protein
fuse
last
amino
acid
ndf
f
protein
third
protein
express
cytoplasm
tail
ct
protein
replac
last
amino
acid
ndv
f
protein
ct
ct
modif
done
enhanc
incorpor
ibv
protein
ndv
envelop
protect
efficaci
three
ibv
protein
evalu
homolog
challeng
egyptian
strain
human
epidermoid
carcinoma
chicken
embryo
fibroblast
cell
line
cultur
dulbecco
minim
essenti
medium
dmem
fetal
bovin
serum
specif
pathogen
free
spf
embryon
chicken
egg
ece
obtain
charl
river
laboratori
manassa
va
usa
egyptian
ibv
strain
belong
lineag
genbank
access
number
ndv
strain
lasota
virul
ndv
strain
texa
gb
genbank
access
number
modifi
vaccinia
strain
ankara
express
polymeras
kind
gift
dr
bernard
moss
use
studi
work
relat
virul
ndv
perform
usda
certifi
enhanc
anim
biosafeti
level
facil
three
differ
form
chickencodonoptim
gene
egyptian
ibv
strain
insert
individu
phosphoprotein
p
matrix
protein
gene
lasota
antigenom
cdna
backbon
use
pmei
site
gener
three
differ
recombin
ndv
vector
ibv
vaccin
candid
figur
first
recombin
rlasotawt
full
chickencodonoptim
sequenc
ibv
gene
without
modif
insert
second
recombin
rlasota
tyrosin
residu
present
posit
ibv
protein
mutat
alanin
pcr
mutagenesi
modifi
gene
fuse
last
amino
acid
ndv
fusion
f
protein
cytoplasm
domain
use
overlap
pcr
third
recombin
cytoplasm
tail
ibv
gene
replac
last
amino
acid
ndv
fusion
protein
use
fusion
pcr
techniqu
three
form
ibv
gene
insert
independ
transcript
cassett
flank
genestart
gs
geneend
ge
sequenc
ndv
rule
six
ensur
final
length
recombin
ndv
genom
effici
replic
briefli
codonoptim
ibv
ge
intergen
sequenc
ig
gs
kozak
sequenc
flank
pmei
synthes
clone
addit
file
construct
rlasotawt
digest
pmei
neb
releas
insert
gel
purifi
ligat
fulllength
rlasota
clone
predigest
pmei
dephosphoryl
thermost
shrimp
alkalin
phosphatas
tsap
promega
construct
rlasota
primer
set
use
induc
add
last
aa
ndv
f
protein
use
templat
tabl
two
pcr
product
fuse
use
primer
fusion
pcr
fuse
pcr
product
digest
smai
stui
neb
ligat
predigest
smai
stui
sequenc
natur
present
downstream
gene
creat
addit
file
construct
primer
set
use
replac
cytoplasm
tail
ibv
protein
last
aa
ndv
f
protein
use
templat
pcr
product
digest
smai
stui
ligat
predigest
smai
stui
creat
addit
file
newli
form
digest
pmei
releas
insert
ligat
individu
fulllength
rlasota
clone
predigest
pmei
dephosphoryl
tsap
construct
rlasota
respect
sequenc
insert
confirm
dna
nucleotid
sequenc
recombin
virus
rescu
use
revers
genet
techniqu
previous
describ
rescu
recombin
virus
plaqu
purifi
propag
spf
ece
infect
allanto
fluid
harvest
aliquot
store
work
insert
differ
form
ibv
gene
detect
rtpcr
use
lasota
specif
primer
flank
pmei
site
confirm
nucleotid
sequenc
compar
multicycl
growth
kinet
rlasotawt
rlasota
parent
rlasota
cell
cultur
sixwel
plate
infect
recombin
virus
moi
h
viru
adsorpt
cell
wash
twice
serumfre
dmem
incub
dmem
contain
fb
normal
allanto
fluid
incub
supernat
media
collect
well
h
interv
h
replac
equal
volum
fresh
dmem
fb
allanto
fluid
time
viru
titer
collect
supernat
sampl
determin
tissu
cultur
infect
dose
titrat
assay
briefli
dilut
sampl
inocul
cell
monolay
plate
four
replic
well
use
dilut
h
adsorpt
cell
monolay
overlaid
dmem
contain
fb
normal
allanto
fluid
incub
incub
day
calcul
accord
reed
muench
method
check
genet
stabil
three
recombin
virus
passag
time
ece
presenc
differ
form
gene
check
rtpcr
use
onestep
rtpcr
kit
new
england
inc
dna
sequenc
use
termin
cycl
sequenc
kit
appli
biosystem
usa
abi
genet
analyz
appli
biosystem
surfac
intracellular
express
differ
form
gene
examin
infect
cell
immunofluoresc
western
blot
analys
briefli
cell
grown
confluenc
glass
slide
chamber
nunc
ii
thermofish
usa
infect
viru
moi
two
chamber
use
viru
hour
postinfect
hpi
cell
fix
paraformaldehyd
solut
min
quench
mm
glycin
min
cell
permeabil
triton
min
demonstr
surfac
express
cell
permeabil
step
exclud
cell
block
goat
serum
min
incub
chicken
polyclon
antiibv
antibodi
gener
egyptian
strain
dilut
h
goat
antichicken
fluorescein
isothiocyan
fitc
conjug
antibodi
dilut
min
step
carri
room
temperatur
cell
nuclei
stain
dapi
cell
visual
confoc
zeiss
lsm
fluoresc
microscop
western
blot
analysi
infect
cell
lyse
radioimmunoprecipit
assay
ripa
buffer
incub
ice
min
clarifi
centrifug
maximum
speed
supernat
mix
sampl
buffer
mm
ph
sd
mm
dtt
bromophenol
blue
glycerol
denatur
heat
boil
water
bath
min
resolv
analyz
western
blot
use
chicken
polyclon
antiibv
antibodi
determin
incorpor
protein
ibv
ndv
particl
recombin
virus
partial
purifi
ultracentrifug
briefli
ml
infect
allanto
fluid
recombin
viru
pass
sucros
cushion
h
rpm
viru
pellet
resuspend
pb
partial
purifi
lasota
viru
use
neg
control
resuspend
pellet
mix
sdspage
sampl
buffer
heat
denatur
resolv
sdspage
analyz
western
blot
use
chicken
polyclon
antiibv
antibodi
pathogen
recombin
ndvvector
ibv
vaccin
candid
viru
compar
parent
lasota
viru
mean
death
time
mdt
assay
spf
ece
briefli
serial
dilut
infect
allanto
fluid
made
steril
pb
dilut
rang
inocul
four
embryon
egg
via
allanto
sac
rout
egg
incub
examin
three
time
daili
day
record
time
embryo
mortal
mdt
determin
mean
time
h
minimum
lethal
dose
viru
kill
inocul
embryo
evalu
protect
efficaci
ibv
sixti
spf
white
leghorn
chicken
divid
group
hous
neg
pressur
isol
feed
water
provid
ad
libitum
four
group
contain
bird
vaccin
rlasota
rlasotawt
rlasota
respect
via
oculonas
rout
fifth
group
contain
bird
serv
unvaccin
control
three
week
postimmun
blood
sampl
collect
bird
determin
level
hemagglutin
inhibit
hi
antibodi
titer
serum
ndv
antibodi
respons
ibv
use
elisa
blood
collect
bird
vaccin
group
bird
unvaccin
control
group
challeng
via
oculonas
rout
bird
observ
score
clinic
sign
day
postchalleng
dpc
euthan
use
euthanasia
procedur
approv
iacuc
univers
maryland
score
includ
normal
mild
ocular
discharg
mild
nasal
discharg
andor
sneez
heavi
ocular
discharg
heavi
nasal
discharg
andor
cough
tracheal
rale
andor
mouth
breath
dpc
tracheal
oropharyng
swab
collect
bird
detect
level
viral
shed
base
ibvspecif
onestep
univers
probe
rtqpcr
kit
evalu
protect
efficaci
ndv
bird
group
vaccin
rlasota
rlasota
addit
unvaccin
control
group
challeng
chicken
lethal
dose
virul
ndv
strain
texa
gb
via
oculonas
rout
facil
ndv
strain
texa
gb
use
ndv
challeng
strain
us
bird
observ
clinic
sign
mortal
dpc
ibv
ndv
challeng
studi
deathmort
endpoint
bird
score
physic
appear
physic
activ
neurolog
andor
respiratori
sign
reach
cumul
score
bird
euthan
use
euthanasia
procedur
approv
iacuc
univers
maryland
euthan
bird
score
dead
day
fifti
spf
white
leghorn
chick
divid
group
bird
hous
neg
pressur
isol
feed
water
provid
ad
libitum
bird
group
immun
prime
pfu
rlasota
rlasotawt
rlasota
respect
day
age
boost
day
age
via
oculonas
rout
bird
group
number
serv
unvaccin
control
day
age
week
postboost
bird
group
challeng
via
ocular
rout
clinic
sign
record
daili
dpc
dpc
tracheal
oropharyng
swab
collect
bird
determin
level
viral
shed
use
ibvspecif
itaq
onestep
univers
probe
rtqpcr
kit
blood
sampl
collect
day
age
challeng
determin
serum
hi
antibodi
titer
ndv
antibodi
respons
ibv
use
elisa
ibvspecif
immun
respons
determin
use
elisa
briefli
elisa
plate
nunc
maxisorp
coat
heatinactiv
purifi
carbonatebicarbon
buffer
ph
overnight
ibvcoat
plate
block
skim
milk
powder
pb
overnight
plate
load
serum
sampl
dilut
skim
milk
h
room
temperatur
plate
wash
ibvspecif
antibodi
detect
use
reagent
commerci
ibv
elisa
kit
synbiot
usa
accord
manufactur
instruct
absorb
optic
densiti
measur
nm
use
biotek
elisa
reader
statist
signific
differ
group
determin
use
oneway
analysi
varianc
anova
follow
tukey
multipl
comparison
test
use
prism
graphpad
softwar
inc
san
diego
ca
p
valu
three
form
ibv
gene
insert
fulllength
cdna
clone
ndv
strain
lasota
p
gene
correspond
recombin
virus
rlasotawt
rlasota
success
rescu
rtpcr
dna
sequenc
confirm
presenc
three
differ
form
ibv
gene
rlasota
genom
fifth
passag
ece
presenc
ibv
gene
detect
rtpcr
three
recombin
virus
confirm
dna
sequenc
indic
recombin
virus
genet
stabl
express
protein
rndv
detect
western
blot
western
blot
analysi
infect
cell
lysat
reveal
three
band
indic
protein
ibv
howev
band
detect
mock
rlasotainfect
cell
figur
top
panel
express
protein
rndv
confirm
immunofluoresc
immunofluoresc
analysi
show
intracellular
express
ibv
protein
cell
infect
rlasotawt
wherea
intracellular
surfac
express
ibv
protein
observ
cell
infect
rlasota
express
ibv
protein
detect
mock
rlasotainfect
cell
figur
determin
whether
protein
express
rndv
incorpor
ndv
virion
rndv
collect
infect
egg
partial
purifi
sucros
cushion
western
blot
analysi
partial
purifi
recombin
virus
show
express
ibv
protein
rlasota
rlasotawt
rlasota
indic
fusion
last
amino
acid
ndv
fusion
protein
result
incorpor
ibv
protein
ndv
virion
figur
bottom
panel
multicycl
growth
kinet
rlasotawt
rlasota
evalu
cell
presenc
exogen
proteas
growth
three
recombin
compar
parent
rlasota
growth
rlasotawt
rlasota
slightli
lower
parent
rlasota
till
hpi
hpi
reach
titer
similar
parent
rlasota
rlasota
rlasotawt
rlasota
reach
maximum
titer
respect
hpi
reach
maximum
titer
hpi
figur
pathogen
rndv
evalu
ece
mdt
assay
rlasotawt
rlasota
show
mdt
valu
h
h
h
respect
higher
parent
rlasota
h
indic
slightli
attenu
parent
rlasota
evalu
protect
efficaci
rndv
express
ibv
protein
spf
chick
immun
singledos
viru
challeng
week
egyptian
strain
bird
group
show
respiratori
sign
vari
sever
includ
lacrim
nasal
discharg
sneez
cough
tracheal
rale
mouth
breath
start
dpc
bird
vaccin
rlasotawt
rlasota
show
significantli
milder
sign
bird
control
rlasotavaccin
group
especi
dpc
figur
rtqpcr
result
show
signific
reduct
tracheal
shed
ibv
control
vaccin
group
figur
ibv
specif
antibodi
produc
vaccin
bird
assess
elisa
week
postimmun
chicken
vaccin
rlasota
show
signific
increas
elisa
antibodi
titer
compar
control
nonvaccin
group
p
p
respect
howev
chicken
vaccin
rlasota
rlasotawt
show
ibv
specif
elisa
antibodi
titer
figur
protect
efficaci
rndv
express
ibv
protein
evalu
virul
strain
ndv
upon
challeng
velogen
ndv
strain
texa
gb
bird
group
vaccin
rlasota
rlasota
show
clinic
sign
mortal
wherea
bird
control
group
show
sever
nervou
sign
euthan
dpc
result
suggest
rndv
vector
ibv
vaccin
provid
protect
also
ndv
antibodi
titer
vaccin
bird
evalu
hi
test
three
week
postimmun
prior
challeng
mean
serum
hi
antibodi
titer
ndv
group
vaccin
rlasotawt
rlasota
reach
valu
significantli
lower
rlasotavaccin
group
figur
spf
chick
evalu
protect
efficaci
challeng
egyptian
strain
primeboost
immun
rndv
express
ibv
protein
challeng
bird
group
vaccin
rlasotawt
rlasota
show
significantli
lower
clinic
sign
score
bird
control
rlasotavaccin
group
dpc
p
figur
rtqpcr
result
reveal
signific
reduct
ibv
shed
bird
vaccin
rlasotawt
p
compar
control
group
wherea
bird
vaccin
rlasota
show
littl
signific
reduct
ibv
shed
compar
control
group
figur
ibv
specif
antibodi
elicit
vaccin
bird
primeboost
vaccin
assess
elisa
three
week
boost
chicken
vaccin
rlasota
show
significantli
higher
elisa
antibodi
titer
compar
control
nonvaccin
group
p
howev
chicken
vaccin
rlasota
rlasotawt
show
ibv
specif
elisa
antibodi
titer
figur
antibodi
titer
ndv
vaccin
bird
evalu
hi
test
two
week
first
vaccin
boost
mean
serum
hi
titer
ndv
induc
three
recombin
ndv
express
differ
form
ibv
gene
reach
significantli
lower
induc
parent
rlasota
three
week
boost
challeng
mean
serum
hi
titer
group
increas
compar
rlasota
figur
ib
major
diseas
problem
poultri
industri
egypt
current
classic
variant
liveattenu
ibv
vaccin
wide
use
egypt
control
ib
vaccin
highli
success
control
classic
ibv
strain
egypt
howev
vaccin
provid
good
protect
circul
variant
strain
belong
lineag
ibv
preval
egypt
liveattenu
vaccin
belong
lineag
may
provid
better
protect
preval
field
strain
develop
new
liveattenu
vaccin
expens
time
consum
furthermor
liveattenu
vaccin
may
revert
virul
contribut
creation
new
variant
virus
therefor
develop
vector
vaccin
preval
egyptian
ibv
variant
strain
develop
vector
vaccin
rapid
lead
creation
new
ibv
variant
studi
three
ndvvector
vaccin
candid
gener
use
three
differ
form
protein
egyptian
ibv
strain
rlasotawt
rlasota
ibv
protein
rlasota
modifi
abolish
intracellular
retent
signal
facilit
transport
ibv
protein
cell
surfac
done
hypothes
present
ibv
protein
cell
surfac
would
elicit
better
humor
immun
respons
addit
modifi
protein
fuse
last
amino
acid
ndv
f
protein
facilit
incorpor
ndv
virion
envelop
whole
protein
use
vaccin
antigen
instead
protein
protein
highli
conform
depend
critic
neutral
epitop
protein
form
amino
acid
protein
epitop
lost
separ
recent
confirm
shirvani
et
al
present
studi
evalu
two
addit
form
protein
evalu
shirvani
et
al
studi
ndv
chosen
vaccin
vector
ibv
consid
vaccin
protect
ib
nd
enzoot
egypt
three
ndvvector
ibv
vaccin
candid
express
protein
ibv
high
level
five
passag
ece
indic
gene
insert
genet
stabl
result
show
three
vaccin
candid
grew
high
titer
ece
hau
make
suitabl
mass
vaccin
product
vaccin
candid
slightli
attenu
compar
parent
rlasota
viru
mdt
assay
onedayold
chicken
immun
three
rndv
express
ibv
protein
show
clinic
protect
challeng
egyptian
ibv
strain
although
three
ibv
vaccin
candid
significantli
reduc
sever
clinic
sign
show
reduct
tracheal
viral
shed
anoth
import
criterion
determin
efficaci
ibv
vaccin
result
indic
immun
respons
elicit
singl
immun
may
high
enough
stop
viru
shed
respiratori
tract
note
ibv
highli
infecti
fast
replic
viru
therefor
requir
high
level
high
affin
neutral
antibodi
cell
mediat
immun
respons
complet
block
ibv
replic
respiratori
tract
achiev
liveattenu
ibv
vaccin
result
agreement
previou
report
rndv
express
protein
prevent
diseas
stop
viru
shed
anoth
possibl
explan
chick
may
immatur
immun
system
could
elicit
robust
protect
immun
respons
singl
immun
shown
vaccin
spf
chick
ibv
vaccin
day
age
lesser
extent
day
age
provid
poorli
protect
ibv
specif
immun
respons
vaccin
day
age
older
provid
better
protect
ibv
challeng
primeboost
immun
studi
rlasotawt
provid
signific
protect
term
allevi
clinic
sign
reduct
tracheal
viral
shed
ibv
challeng
howev
rlasota
provid
protect
clinic
diseas
significantli
decreas
tracheal
viral
shed
could
ibv
protein
case
rlasotawt
elicit
effect
cell
mediat
immun
respons
crucial
clearanc
ibv
respiratori
tract
also
report
humor
antibodi
titer
correl
resist
respiratori
infect
anoth
possibl
explan
modif
done
protein
ibv
rlasota
could
chang
conform
ibv
protein
andor
render
loss
critic
cell
epitop
necessari
effect
block
ibv
infect
result
suggest
wild
type
protein
ibv
best
protect
antigen
modif
protein
affect
protect
efficaci
protein
notabl
rlasotawt
provid
signific
protect
ibv
challeng
primeboost
vaccin
experi
even
though
challeng
dose
increas
per
bird
indic
primeboost
vaccin
strategi
provid
protect
immun
respons
high
dose
ibv
challeng
also
need
investig
singledos
vaccin
chicken
older
age
older
may
enough
provid
protect
immun
respons
ibv
challeng
due
welldevelop
immun
system
age
elisa
result
show
rlasotawt
produc
signific
increas
ibvspecif
serum
antibodi
titer
hand
rlasota
show
signific
increas
ibvspecif
antibodi
titer
possibl
explan
surfac
express
ibv
protein
incorpor
ndv
virion
case
rlasota
elicit
much
stronger
humor
immun
respons
compar
rlasotawt
show
intracellular
express
protein
moreov
coat
elisa
plate
inactiv
whole
ibv
could
also
increas
detect
threshold
ibvspecif
humor
antibodi
rais
protein
alon
similarli
eldemeri
cowork
report
higher
level
antibodi
ibv
protein
sectodomaincoatedelisa
plate
use
compar
wholeviruscoatedpl
summari
recombin
ndv
strain
lasota
express
three
differ
form
chickencodonoptim
protein
preval
egyptian
ibv
variant
strain
gener
evalu
use
bival
vaccin
egypt
studi
confirm
extend
work
shirvani
et
al
whole
protein
antigen
choic
gener
effici
vector
ibv
vaccin
result
show
modif
protein
affect
protect
efficaci
result
show
recombin
ndv
express
wild
type
protein
egyptian
variant
strain
rlasotawt
provid
protect
clinic
diseas
preval
egyptian
variant
strain
ibv
reduc
viru
shed
primeboost
immun
indic
vaccin
candid
potenti
control
ibv
egypt
furthermor
ndvvector
ibv
vaccin
protect
ibv
ndv
vaccin
also
benefit
countri
neighbor
egypt
antigen
similar
ibv
strain
preval
thu
suggest
similar
ndvvector
vaccin
engin
use
circul
ibv
strain
geograph
region
